Stocks News

LAST PRICE
68.6800
TODAY'S CHANGE (%)
Trending Down-1.1800 (-1.6891%)

Bid / Lots
28.8900/ 1
Ask / Lots
77.7200/ 1
Open / Previous Close
69.5000 / 69.8600
Day Range
Low 68.0700
High 69.5900
52 Week Range
Low 54.4800
High 77.7200
Volume
379,195
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 31, 2024
- Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading, from 10:44AM ET on Friday May 31, 2024 by MT Newswires
  10:44AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: HDB, INFY, NMR, PHI, RDY, SIFY, TLK, SE, ASLN, HUYA, JG, DUO, BQ, HKD, CMCM, XNET
  10:44 AM EDT, 05/31/2024 (MT Newswires) -- Asian equities traded in the US as American depositary receipts were trending lower Friday morning, declining 0.7% to 1,905.87 on the S&P Asia 50 ADR Index, which is down approximately 1.3% for the week. ...
May 28, 2024
- Asian Equities Traded in the US as American Depositary Receipts Open Week Slightly Lower in Tuesday Trading, from 10:43AM ET on Tuesday May 28, 2024 by MT Newswires
  10:43AM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: SOL, HDB, IBN, NCTY, RDY, SIFY, WIT, SE, ASLN, UXIN, JG, CANG, BQ, CMCM, BZUN
  10:43 AM EDT, 05/28/2024 (MT Newswires) -- Asian equities traded in the US as American depositary receipts opened the week modestly lower Tuesday morning, declining 0.19% to 1,947.18 on the S&P Asia 50 ADR Index. From North Asia, the gainers were ...
- Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America, from 9:53AM ET on Tuesday May 28, 2024 by Dow Jones
  9:53AM ET on Tuesday May 28, 2024 by Dow Jones
  Companies Mentioned: RDY
  HYDERABAD, India--(BUSINESS WIRE)--May 28, 2024--
  Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member of the Management Council. As part of the Dr. Reddy's senior leadership team, he will be responsible for the company's North America business and will be based out of the Princeton, New Jersey, U.S. office.
- *DJ Dr. Reddy's Laboratories Announces The Appointment Of Milan Kalawadia To CEO North America >RDY, from 9:53AM ET on Tuesday May 28, 2024 by Dow Jones
  9:53AM ET on Tuesday May 28, 2024 by Dow Jones
  Companies Mentioned: RDY
May 24, 2024
- Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Lower, from 10:39AM ET on Friday May 24, 2024 by MT Newswires
  10:39AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: SOL, HDB, IBN, CCM, JKS, RDY, SIFY, WIT, ZLAB, ASLN, WNS, DOYU, KRKR, BQ, TOUR
  10:39 AM EDT, 05/24/2024 (MT Newswires) -- Asian equities traded in the US as American depositary receipts were trending higher Friday morning, rising 1.01% to 1,951.87 on the S&P Asia 50 ADR Index. Despite the gain, the index is set to close out th...

Yesterday
- IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 19 hours ago by Accesswire
  19 hours ago by Accesswire
  Companies Mentioned: MRNS
May 31, 2024
- IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 4:16PM ET on Friday May 31, 2024 by Accesswire
  4:16PM ET on Friday May 31, 2024 by Accesswire
  Companies Mentioned: MRNS
May 30, 2024
- IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:47PM ET on Thursday May 30, 2024 by Accesswire
  12:47PM ET on Thursday May 30, 2024 by Accesswire
  Companies Mentioned: MRNS
May 29, 2024
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 1:04PM ET on Wednesday May 29, 2024 by Accesswire
  1:04PM ET on Wednesday May 29, 2024 by Accesswire
  Companies Mentioned: MRNS
- Equillium to Present at the Jefferies Global Healthcare Conference, from 8:00AM ET on Wednesday May 29, 2024 by Business Wire
  8:00AM ET on Wednesday May 29, 2024 by Business Wire
  Companies Mentioned: EQ
May 28, 2024
- INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 1:46PM ET on Tuesday May 28, 2024 by Accesswire
  1:46PM ET on Tuesday May 28, 2024 by Accesswire
  Companies Mentioned: MRNS
May 26, 2024
- INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:05AM ET on Sunday May 26, 2024 by Accesswire
  11:05AM ET on Sunday May 26, 2024 by Accesswire
  Companies Mentioned: MRNS
- INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:05AM ET on Sunday May 26, 2024 by Accesswire
  11:05AM ET on Sunday May 26, 2024 by Accesswire
  Companies Mentioned: MRNS
May 25, 2024
- IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:04AM ET on Saturday May 25, 2024 by Accesswire
  11:04AM ET on Saturday May 25, 2024 by Accesswire
  Companies Mentioned: MRNS
May 24, 2024
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:48PM ET on Friday May 24, 2024 by Accesswire
  12:48PM ET on Friday May 24, 2024 by Accesswire
  Companies Mentioned: MRNS

Dr Reddy's Laboratories Ltd
NYSE:RDYUnited States

Search Criteria

May 31, 2024

Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading, from 10:44AM ET on Friday May 31, 2024 by MT Newswires

May 28, 2024

Asian Equities Traded in the US as American Depositary Receipts Open Week Slightly Lower in Tuesday Trading, from 10:43AM ET on Tuesday May 28, 2024 by MT Newswires

Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America, from 9:53AM ET on Tuesday May 28, 2024 by Dow Jones

*DJ Dr. Reddy's Laboratories Announces The Appointment Of Milan Kalawadia To CEO North America >RDY, from 9:53AM ET on Tuesday May 28, 2024 by Dow Jones

May 24, 2024

Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Lower, from 10:39AM ET on Friday May 24, 2024 by MT Newswires

Peers Headlines

Yesterday

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 19 hours ago by Accesswire

May 31, 2024

IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 4:16PM ET on Friday May 31, 2024 by Accesswire

May 30, 2024

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:47PM ET on Thursday May 30, 2024 by Accesswire

May 29, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 1:04PM ET on Wednesday May 29, 2024 by Accesswire

Equillium to Present at the Jefferies Global Healthcare Conference, from 8:00AM ET on Wednesday May 29, 2024 by Business Wire

May 28, 2024

INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 1:46PM ET on Tuesday May 28, 2024 by Accesswire

May 26, 2024

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:05AM ET on Sunday May 26, 2024 by Accesswire

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:05AM ET on Sunday May 26, 2024 by Accesswire

May 25, 2024

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:04AM ET on Saturday May 25, 2024 by Accesswire

May 24, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:48PM ET on Friday May 24, 2024 by Accesswire